Tramway Ventures

Tramway Ventures is a venture capital firm established in 2017 and located in Albuquerque, New Mexico. The firm specializes in investments within the information technology, life sciences, and healthcare sectors, focusing on innovative companies that demonstrate potential for growth and impact in these fields. Through its investment strategies, Tramway Ventures aims to support emerging businesses that are poised to advance technological and healthcare solutions.

Waneta Tuttle

Managing Partner

Chris Japp

Managing Partner

Past deals in New Mexico

Circular Genomics

Series A in 2024
Circular Genomics is a company based in Albuquerque, New Mexico, specializing in the development of circular RNA diagnostics to enhance precision medicine in the treatment of neurological and psychiatric conditions. Founded in 2021, the company aims to improve the diagnosis and treatment of depressive disorders by utilizing circular RNA as a novel biomarker. This innovative approach allows for evidence-based treatment strategies, significantly reducing the time required for patients to achieve a therapeutic response. By focusing on the potential of circular RNA, Circular Genomics is positioning itself as a leader in the field of psychiatric and neurological diagnostics, enabling healthcare professionals to better address complex mental health issues.

Vitazi.ai

Seed Round in 2022
Vitazi.ai is an early-stage start-up located in Santa Fe, New Mexico, specializing in the development of diagnostic technology for disease detection through artificial intelligence. The company has created the first comprehensive end-to-end solution for diabetic retinopathy detection, integrating both hardware and software tailored to the specific needs of healthcare providers. This innovative system enables real-time and accurate evaluation of patients, helping to meet quality metrics and improve reimbursement processes while addressing the long-term challenges associated with preventable vision loss and blindness. Vitazi.ai aims to enhance the capabilities of healthcare professionals and improve patient outcomes through its advanced diagnostic tools.

Circular Genomics

Seed Round in 2021
Circular Genomics is a company based in Albuquerque, New Mexico, specializing in the development of circular RNA diagnostics to enhance precision medicine in the treatment of neurological and psychiatric conditions. Founded in 2021, the company aims to improve the diagnosis and treatment of depressive disorders by utilizing circular RNA as a novel biomarker. This innovative approach allows for evidence-based treatment strategies, significantly reducing the time required for patients to achieve a therapeutic response. By focusing on the potential of circular RNA, Circular Genomics is positioning itself as a leader in the field of psychiatric and neurological diagnostics, enabling healthcare professionals to better address complex mental health issues.

WaveDyn Vision

Venture Round in 2020
WaveDyn Vision is an early-stage medical device company with innovative wavefront diagnostic technology for use in the vision care industry. It plans to leverage its proprietary dynamic wavefront measurement technology to yield new insights into assessing visual performance, advancing treatment options, and improving the quality of life for the visually impaired. The company was founded in 2019 and is based in Albuquerque, New Mexico.

BennuBio

Series B in 2020
BennuBio, Inc. is a technology company specializing in the development of flow cytometry equipment designed for the sorting and analysis of cells and particles in various applications, particularly those requiring the recovery of rare cells. The company offers The Velocyt system, which enables the detection of rare events such as activated T cells, circulating tumor cells, and fetal cells in maternal blood, supporting advancements in personalized medicine and drug discovery. Additionally, BennuBio provides spheroid generation systems and high-volume sorting systems, along with technical and application support services. Founded in 2018 and based in Albuquerque, New Mexico, BennuBio focuses on delivering innovative cell analysis solutions that accommodate a wide range of sample sizes and particle dimensions.

BennuBio

Series A in 2018
BennuBio, Inc. is a technology company specializing in the development of flow cytometry equipment designed for the sorting and analysis of cells and particles in various applications, particularly those requiring the recovery of rare cells. The company offers The Velocyt system, which enables the detection of rare events such as activated T cells, circulating tumor cells, and fetal cells in maternal blood, supporting advancements in personalized medicine and drug discovery. Additionally, BennuBio provides spheroid generation systems and high-volume sorting systems, along with technical and application support services. Founded in 2018 and based in Albuquerque, New Mexico, BennuBio focuses on delivering innovative cell analysis solutions that accommodate a wide range of sample sizes and particle dimensions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.